Latest filing published 26 Oct 2021 for Xilio Therapeutics, Inc..
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
RiverVest Venture Fund IV, L.P.: trading record in brief
RiverVest Venture Fund IV, L.P. appears in our data through filings on Xilio Therapeutics, Inc. shares, published by SEC (Form 4). Activity is concentrated on a single trading day, 26 October 2021, with 3 filings.
Every open-market trade on record is a purchase: 1 purchase worth €3.4M, and no sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
The record was last updated on 26 October 2021 with an open-market purchase (€3.4M) in Xilio Therapeutics, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to RiverVest Venture Fund IV, L.P.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 832,120 sharesCommon StockSEC:0000899243-21-041580:0
1 of 1 declaration